RecallRadar

FDA Drug recall D-0049-2015

Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd

On 2014-11-05 the FDA classified a Class III recall of Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd by Taro Pharmaceuticals U, citing marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate man….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0049-2015
ClassificationClass III
Statusterminated
Initiated2014-10-21
Published2014-11-05
Last updated2026-09-13 11:51 UTC
CompanyTaro Pharmaceuticals U
DistributionIL, LA, OH

Product

Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 26110 Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4005-3.

Reason

Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval.

Identifiers

ndc51672-4041-1
ndc51672-4041-2
ndc51672-4041-9
ndc51672-4041-0
ndc51672-4050-1
ndc51672-4005-1
ndc51672-4005-2
ndc51672-4005-3
ndc51672-4123-6
ndc51672-4123-1
ndc51672-4123-3
ndc51672-4124-6
ndc51672-4124-1
ndc51672-4124-3
ndc51672-4125-6
ndc51672-4125-1
ndc51672-4125-3
ndc51672-4047-9
ndc51672-4047-4
code_infoLot 137393, exp. 10/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0049-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.